PGR and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) comprises a heterogeneous disease group defined by lack of estrogen receptor (ER), progesterone receptor (PR), and HER2 expression and is often associated with increased genomic instability, high mitotic rates and poor prognosis (1, 2).